GlassScriptPhysician profile
David C Zisa
NPI 1962763789
$3,115.83
in general payments reported to CMS, 2019-2025
19 companies · $63.83 in 2025
The $63.83 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,718 · 2020: $180 · 2021: $408 · 2022: $572 · 2023: $96.33 · 2024: $77.69 · 2025: $63.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $188 · Consulting Fee: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $187.85 |
| Consulting Fee | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $931.98 | 2019-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Pfizer INC. | $264.14 | 2020-2022 | |
| Abiomed | $258.11 | 2019-2024 | Impella |
| Medtronic, INC. | $221.84 | 2021-2025 | Sprinter Legend |
| Janssen Pharmaceuticals, INC | $155.77 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $144.60 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $128.43 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $128.38 | 2020-2024 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $122.12 | 2019-2025 | Lifevest |
| Abbott Laboratories | $114.31 | 2019-2024 | Ultreon |
| Amarin Pharma, INC. | $108.29 | 2019-2022 | |
| Boston Scientific Corporation | $102.83 | 2019 | |
| Astellas Pharma US INC | $99.99 | 2019 | |
| Cardinal Health 200 LLC | $91.79 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $89.81 | 2020-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $87.30 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $35.65 | 2019 | |
| Merck Sharp & Dohme LLC | $16.34 | 2022 | |
| Chiesi USA, INC. | $14.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Zisa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.